Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

COMP grants perifosine positive opinion as orphan medicinal product in MM

March 2, 2010

UCB presents novel PI3K inhibitors

March 2, 2010

Genentech identifies novel MEK inhibitors

March 2, 2010

AstraZeneca discloses novel FGFR inhibitors

March 2, 2010

Virginia G. Piper Cancer Center and TGen begin phase I trial of Pharmacyclics' PCI-32765 in cancer

March 1, 2010

FDA issues refuse to file letter to Adventrx on vinorelbine NDA

March 1, 2010

Novel dual PI3K alpha and mTOR inhibitors described by S*BIO

March 1, 2010

Merck KGaA identifies novel PDK1 inhibitors

March 1, 2010

Sunesis poised to begin phase III voreloxin trial in AML

Feb. 26, 2010

EMA approves OncoGenex's development plan for OGX-011

Feb. 26, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...